Ajanta Pharma Limited — Losartan Exporter Profile
Indian Pharmaceutical Exporter · #7 for Losartan · $3.5M export value · DGFT Verified
Ajanta Pharma Limited is the #7 Indian exporter of Losartan with $3.5M in export value and 69 verified shipments. Ajanta Pharma Limited holds a 1.1% market share in Losartan exports across 2 countries. The company exports 37 pharmaceutical products worth $116.1M across 17 therapeutic categories.
Ajanta Pharma Limited — Losartan Export Profile: Buyers & Destinations
Where Does Ajanta Pharma Limited Export Losartan?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $2.9M | 68 | 99.8% |
| FRANCE | $4.9K | 1 | 0.2% |
Ajanta Pharma Limited exports Losartan to 2 countries. The largest destination is PHILIPPINES accounting for 99.8% of Ajanta Pharma Limited's Losartan shipments. These destinations reflect Ajanta Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Losartan from Ajanta Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| UNILAB INC | PHILIPPINES | $2.9M | 68 |
| PLANET PHARMA SA | FRANCE | $4.9K | 1 |
Ajanta Pharma Limited supplies Losartan to 2 buyers globally. The largest buyer is UNILAB INC (PHILIPPINES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Losartan Export Value and How Much Does Ajanta Pharma Limited Contribute?
India exported $143.4M worth of Losartan through 10,898 shipments from 506 suppliers to 141 countries, serving 1,415 buyers globally. Ajanta Pharma Limited contributes $3.5M to this total, accounting for 1.1% of India's Losartan exports. Ajanta Pharma Limited ships Losartan to 2 countries through 2 buyers.
What Is the Average Shipment Value for Ajanta Pharma Limited's Losartan Exports?
Ajanta Pharma Limited's average Losartan shipment value is $50.0K per consignment, based on 69 shipments totaling $3.5M. The largest destination is PHILIPPINES (99.8% of Ajanta Pharma Limited's Losartan exports).
How Does Ajanta Pharma Limited Compare to Other Indian Losartan Exporters?
Ajanta Pharma Limited ranks #7 among 506 Indian Losartan exporters with a 1.1% market share. The top 3 exporters are ZYDUS LIFESCIENCES LIMITED ($28.1M), MICRO LABS LIMITED ($20.5M), AUROBINDO PHARMA LTD ($13.0M). Ajanta Pharma Limited processed 69 shipments to 2 destination countries.
What Losartan Formulations Does Ajanta Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| AMLIFE TAB 50 5 MG 104340 X 3 X 10 3130200 TABLETS LOSARTAN POTASSIUM 50MG AMLODIPINE 5MG TABLETS EACH FILM COATED | $150.0K | 3 |
| AMLIFE TAB 100/5 MG (78540 X 3 X 10 = 2356200 TABLETS) (LOSARTAN POTASSIUM 100MG + AMLODIPINE 5MG TABLETS EAC | $150.0K | 3 |
| AMLIFE TAB 50/5 MG (157580 X3X10=4727400 TABLETS)(LOSARTAN POTASSIUM50MG+AMLODIPINE 5MG TABLETS EACH FILM CO | $150.0K | 3 |
| AMLIFE TAB 100/10 MG (39532 X 3 X 10=1185960 TABLTES)(LOSARTAN POTASSIUM 100 MG + AMLODIPINE 10MG TABLETS EAC | $149.2K | 3 |
| AMLIFE TAB 100/10 MG (39315 X 3 X 10 = 1179450 TABLETS) (LOSARTAN POTASSIUM 100MG + AMLODIPINE 10MG TABLETS E | $143.0K | 3 |
| AMLIFE TAB 50/5 MG (51840 X 3 X 10 = 1555200 TABLETS)(LOSARTAN POTASSIUM 50MG +AMLODIPINE 5MG TABLETS EACH FILM COATED TNOS | $139.5K | 3 |
| AMLIFE TAB 100/5 MG (39420 X 3 X 10 = 1182600 TABLETS)(LOSARTAN POTASSIUM 100MG+ AMLODIPINE 5MG TABLETS EACH FILM COATENOS | $133.6K | 3 |
| AMLIFE TAB 50 5 MG 157260 X 3 X 10 4717800 TABLETS LOSARTAN POTASSIUM 50MG AMLODIPINE 5MG TABLETS EACH FILM COATED | $50.0K | 1 |
| AMLIFE TAB 50/5 MG 237500 X 3 X 10 = 7125000 TABLETS LOSARTAN POTASSIUM 50MG +AMLODIPINE 5MG TABLETS EACH FILM COATED | $50.0K | 1 |
| AMLIFE TAB 50/5 MG 78480 X 3 X 10 = 2354400 TABLETS LOSARTAN POTASSIUM 50MG +AMLODIPINE 5MG TABLETS EACH FILM COATED | $50.0K | 1 |
Ajanta Pharma Limited exports 54 distinct Losartan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AMLIFE TAB 50 5 MG 104340 X 3 X 10 3130200 TABLETS LOSARTAN with 3 shipments worth $150.0K.
How Does Ajanta Pharma Limited Compare to Nearest Losartan Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 15 | UNICHEM LABORATORIES LIMITED | $5.1M | 203 | 6 | $25.0K |
| 13 | CADILA HEALTHCARE LIMITED | $3.6M | 72 | 11 | $50.0K |
| 7 | AJANTA PHARMA LIMITED ★ | $3.5M | 69 | 2 | $50.0K |
| 10 | APL HEALTHCARE LIMITED | $1.9M | 38 | 1 | $50.0K |
Ajanta Pharma Limited ranks #7 among 506 Indian Losartan exporters. Average shipment value of $50.0K compared to the market average of $283.3K. The closest competitors by value are UNICHEM LABORATORIES LIMITED and CADILA HEALTHCARE LIMITED.
Which Indian Ports Ship Losartan Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,020 | 9.4% |
| NHAVA SHEVA SEA (INNSA1) | 946 | 8.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 886 | 8.1% |
| DELHI AIR CARGO ACC (INDEL4) | 702 | 6.4% |
| DELHI AIR | 672 | 6.2% |
| JNPT/ NHAVA SHEVA SEA | 549 | 5.0% |
| MUNDRA SEA | 491 | 4.5% |
| HYDERABAD ICD | 384 | 3.5% |
What Other Cardiovascular Products Does Ajanta Pharma Limited Export?
Ajanta Pharma Limited also exports these cardiovascular products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Ajanta Pharma Limited's Losartan Exports
Ajanta Pharma's export operations are intricately linked to global trade routes, making them susceptible to geopolitical tensions. The ongoing Israel-Iran conflict has disrupted shipping lanes in the Red Sea, leading to increased freight costs and extended delivery timelines. Such disruptions pose challenges for Indian pharmaceutical exporters like Ajanta, necessitating adaptive logistics strategies to maintain supply chain integrity. (pharmaceuticalcommerce.com)
Conversely, the US-China trade tensions have opened avenues for Indian pharmaceutical companies to strengthen their foothold in the American market. India's pharmaceutical exports to the US surged by 74% in March 2025, indicating a shift in sourcing preferences. Ajanta Pharma can leverage this trend by emphasizing its compliance with stringent US regulatory standards and offering competitive pricing. (business-standard.com)
In the European Union, adherence to the Falsified Medicines Directive (FMD) is paramount. Indian exporters, including Ajanta, must ensure robust serialization and traceability measures to comply with these regulations. Non-compliance could result in restricted market access, underscoring the importance of investing in advanced tracking systems and quality assurance protocols.
Ajanta Pharma Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the US FDA, WHO, and EU GMP setting stringent compliance benchmarks. India has made significant strides in this arena, surpassing the US in the number of FDA-registered generic manufacturing sites, boasting 752 FDA-approved facilities as of 2024. (business-standard.com) Ajanta Pharma's commitment to quality is evident in its adherence to these international standards, facilitating smoother market entry and bolstering its reputation among global stakeholders.
About Ajanta Pharma Limited
Ajanta Pharma Limited exports 37 products worth $116.1M. Beyond Losartan, top products include Artemether, Amlodipine, Clopidogrel, Rosuvastatin, Montelukast. View the complete Ajanta Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Losartan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Losartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Ajanta Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 69 individual customs records matching Ajanta Pharma Limited exporting Losartan, covering 54 formulations to 2 countries via 2 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 141+ countries, 1,415+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Losartan Export Data from Ajanta Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Ajanta Pharma Limited's Losartan exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Ajanta Pharma Limited
Full Company Profile →
37 products · $116.1M total trade · 17 categories
Losartan Stats
Company Overview
Top Products by Ajanta Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Ajanta Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Losartan. For current shipment-level data, contact TransData Nexus.